pd 173074 has been researched along with Kidney Failure, Chronic in 1 studies
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czaya, B | 1 |
| Seeherunvong, W | 1 |
| Singh, S | 1 |
| Yanucil, C | 1 |
| Ruiz, P | 1 |
| Quiroz, Y | 1 |
| Grabner, A | 1 |
| Katsoufis, C | 1 |
| Swaminathan, S | 1 |
| Abitbol, C | 1 |
| Rodriguez-Iturbe, B | 1 |
| Faul, C | 1 |
| Freundlich, M | 1 |
1 other study available for pd 173074 and Kidney Failure, Chronic
| Article | Year |
|---|---|
Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies.
Topics: Adolescent; Animals; Cardio-Renal Syndrome; Cardiomyopathies; Child; Disease Models, Animal; Drug Th | 2019 |